Sarepta Therapeutics (0L35.LSE) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-4.6
-2.44
-0.28
1.88

Details

Expected EPS
-3.206992
Actual EPS
-4.6
Surprise EPS
-1.39
Surprise Percent
-43.44%

Description

⁨Sarepta Therapeutics⁩ (⁦0L35.LSE⁩) has reported earnings of ⁦-4.6⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts